Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease - PubMed (original) (raw)
Case Reports
doi: 10.1097/GIM.0b013e3182088158.
Alan N Mayer, Grant D Syverson, Daniel Helbling, Benedetta B Bonacci, Brennan Decker, Jaime M Serpe, Trivikram Dasu, Michael R Tschannen, Regan L Veith, Monica J Basehore, Ulrich Broeckel, Aoy Tomita-Mitchell, Marjorie J Arca, James T Casper, David A Margolis, David P Bick, Martin J Hessner, John M Routes, James W Verbsky, Howard J Jacob, David P Dimmock
Affiliations
- PMID: 21173700
- DOI: 10.1097/GIM.0b013e3182088158
Free article
Case Reports
Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease
Elizabeth A Worthey et al. Genet Med. 2011 Mar.
Free article
Abstract
Purpose: We report a male child who presented at 15 months with perianal abscesses and proctitis, progressing to transmural pancolitis with colocutaneous fistulae, consistent with a Crohn disease-like illness. The age and severity of the presentation suggested an underlying immune defect; however, despite comprehensive clinical evaluation, we were unable to arrive at a definitive diagnosis, thereby restricting clinical management.
Methods: We sought to identify the causative mutation(s) through exome sequencing to provide the necessary additional information required for clinical management.
Results: After sequencing, we identified 16,124 variants. Subsequent analysis identified a novel, hemizygous missense mutation in the X-linked inhibitor of apoptosis gene, substituting a tyrosine for a highly conserved and functionally important cysteine. X-linked inhibitor of apoptosis was not previously associated with Crohn disease but has a central role in the proinflammatory response and bacterial sensing through the NOD signaling pathway. The mutation was confirmed by Sanger sequencing in a licensed clinical laboratory. Functional assays demonstrated an increased susceptibility to activation-induced cell death and defective responsiveness to NOD2 ligands, consistent with loss of normal X-linked inhibitor of apoptosis protein function in apoptosis and NOD2 signaling.
Conclusions: Based on this medical history, genetic and functional data, the child was diagnosed as having an X-linked inhibitor of apoptosis deficiency. Based on this finding, an allogeneic hematopoietic progenitor cell transplant was performed to prevent the development of life-threatening hemophagocytic lymphohistiocytosis, in concordance with the recommended treatment for X-linked inhibitor of apoptosis deficiency. At >42 days posttransplant, the child was able to eat and drink, and there has been no recurrence of gastrointestinal disease, suggesting this mutation also drove the gastrointestinal disease. This report describes the identification of a novel cause of inflammatory bowel disease. Equally importantly, it demonstrates the power of exome sequencing to render a molecular diagnosis in an individual patient in the setting of a novel disease, after all standard diagnoses were exhausted, and illustrates how this technology can be used in a clinical setting.
Comment in
- A timely arrival for genomic medicine.
Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA, Jacob HJ, Margolis DA. Mayer AN, et al. Genet Med. 2011 Mar;13(3):195-6. doi: 10.1097/GIM.0b013e3182095089. Genet Med. 2011. PMID: 21169843 No abstract available.
Similar articles
- How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
Nielsen OH, LaCasse EC. Nielsen OH, et al. Genet Med. 2017 Feb;19(2):133-143. doi: 10.1038/gim.2016.82. Epub 2016 Jul 14. Genet Med. 2017. PMID: 27416006 Review. - Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
Aguilar C, Lenoir C, Lambert N, Bègue B, Brousse N, Canioni D, Berrebi D, Roy M, Gérart S, Chapel H, Schwerd T, Siproudhis L, Schäppi M, Al-Ahmari A, Mori M, Yamaide A, Galicier L, Neven B, Routes J, Uhlig HH, Koletzko S, Patel S, Kanegane H, Picard C, Fischer A, Bensussan NC, Ruemmele F, Hugot JP, Latour S. Aguilar C, et al. J Allergy Clin Immunol. 2014 Nov;134(5):1131-41.e9. doi: 10.1016/j.jaci.2014.04.031. Epub 2014 Jun 15. J Allergy Clin Immunol. 2014. PMID: 24942515 Clinical Trial. - Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study.
Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, Nakayama Y, Tanaka M, Hoshino A, Kanegane H, Abukawa D, Kure S. Suzuki T, et al. J Clin Immunol. 2017 Jan;37(1):67-79. doi: 10.1007/s10875-016-0339-5. Epub 2016 Oct 17. J Clin Immunol. 2017. PMID: 27747465 - Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease.
Okou DT, Mondal K, Faubion WA, Kobrynski LJ, Denson LA, Mulle JG, Ramachandran D, Xiong Y, Svingen P, Patel V, Bose P, Waters JP, Prahalad S, Cutler DJ, Zwick ME, Kugathasan S. Okou DT, et al. J Pediatr Gastroenterol Nutr. 2014 May;58(5):561-8. doi: 10.1097/MPG.0000000000000302. J Pediatr Gastroenterol Nutr. 2014. PMID: 24792626 Free PMC article. - [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
Xu LJ, Luo YY, Yu JD, Lou JG, Fang YH, Chen J. Xu LJ, et al. Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):43-47. doi: 10.3760/cma.j.issn.0578-1310.2018.01.011. Zhonghua Er Ke Za Zhi. 2018. PMID: 29342997 Review. Chinese.
Cited by
- A novel biallelic 19-bp deletion in the IL10RB gene caused infant-onset inflammatory bowel disease in a consanguineous family: a molecular docking simulation study and literature review.
Motallebi F, Al Sudani ZM, Vaghefi F, Khosravi T, Rahimzadeh A, Kowsari A, Oladnabi M. Motallebi F, et al. Mol Biol Rep. 2024 Jan 28;51(1):223. doi: 10.1007/s11033-024-09248-4. Mol Biol Rep. 2024. PMID: 38281300 Review. - Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease.
Lee J, Sim KM, Kang M, Oh HJ, Choi HJ, Kim YE, Pack CG, Kim K, Kim KM, Oh SH, Kim I, Chang I. Lee J, et al. Sci Rep. 2024 Jan 9;14(1):853. doi: 10.1038/s41598-023-50932-5. Sci Rep. 2024. PMID: 38191507 Free PMC article. - [Genomic newborn screening-research approaches, challenges, and opportunities].
Brennenstuhl H, Schaaf CP. Brennenstuhl H, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Nov;66(11):1232-1242. doi: 10.1007/s00103-023-03777-2. Epub 2023 Oct 13. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023. PMID: 37831095 Free PMC article. Review. German. - Personalizing medicine in Africa: current state, progress and challenges.
Owolabi P, Adam Y, Adebiyi E. Owolabi P, et al. Front Genet. 2023 Sep 19;14:1233338. doi: 10.3389/fgene.2023.1233338. eCollection 2023. Front Genet. 2023. PMID: 37795248 Free PMC article. Review. - Gastrointestinal Infection in South African Children under the Age of 5 years: A Mini Review.
Mafokwane T, Djikeng A, Nesengani LT, Dewar J, Mapholi O. Mafokwane T, et al. Gastroenterol Res Pract. 2023 Aug 23;2023:1906782. doi: 10.1155/2023/1906782. eCollection 2023. Gastroenterol Res Pract. 2023. PMID: 37663241 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases